Cancer Center of Kansas

Witchita, Kansas 67214-3728

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Chronic Myelogenous Leukemia in Chronic Phase, First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis

Studies at this site

• CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib — Completed
• Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer — Completed
• Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients — Completed